Page last updated: 2024-09-05

paromomycin and Deafness, Transitory

paromomycin has been researched along with Deafness, Transitory in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baasov, T; Belakhov, V; Ben-Yosef, T; Chen, F; Cherniavsky, M; Hainrichson, M; Nudelman, I; Pilch, DS; Rebibo-Sabbah, A; Schacht, J	1
Apostolidis, K; Buono, A; Chatzis, MK; Kasabalis, D; Leontides, LS; Petanides, T; Polizopoulou, ZS; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG	1
Asensi-Diez, R; Furones Araujo, D; Gallego Fernández, C	1

Trials

1 trial(s) available for paromomycin and Deafness, Transitory

Article	Year
Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study. Experimental parasitology, 2019, Volume: 206 Topics: Allopurinol; Animals; Cochlea; Creatinine; Dog Diseases; Dogs; Double-Blind Method; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Female; Hearing; Hearing Loss; Injections, Subcutaneous; Kidney; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Neurologic Examination; Paromomycin; Random Allocation; Vestibule, Labyrinth	2019

Article

Year

Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.

Experimental parasitology, 2019, Volume: 206

Topics: Allopurinol; Animals; Cochlea; Creatinine; Dog Diseases; Dogs; Double-Blind Method; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Female; Hearing; Hearing Loss; Injections, Subcutaneous; Kidney; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Neurologic Examination; Paromomycin; Random Allocation; Vestibule, Labyrinth

2019

Other Studies

2 other study(ies) available for paromomycin and Deafness, Transitory

Article	Year
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations. Journal of medicinal chemistry, 2009, May-14, Volume: 52, Issue:9 Topics: Aminoglycosides; Animals; Bacteria; Cadherin Related Proteins; Cadherins; Cell Survival; Chlorocebus aethiops; Codon, Nonsense; COS Cells; Cystic Fibrosis Transmembrane Conductance Regulator; Cytoplasm; Disease; Drug Discovery; Dystrophin; Gentamicins; Hearing Loss; Humans; Oligoribonucleotides; Paromomycin; Protein Biosynthesis; RNA Stability; RNA, Ribosomal; Temperature	2009
[Hearing loss associated with paromomycin treatment in a patient with visceral leishmaniasis]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2017, May-01, Volume: 41, Issue:3 Topics: Adult; Antiparasitic Agents; Hearing Loss; Humans; Leishmaniasis, Visceral; Male; Paromomycin	2017

Article

Year

Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.

Journal of medicinal chemistry, 2009, May-14, Volume: 52, Issue:9

Topics: Aminoglycosides; Animals; Bacteria; Cadherin Related Proteins; Cadherins; Cell Survival; Chlorocebus aethiops; Codon, Nonsense; COS Cells; Cystic Fibrosis Transmembrane Conductance Regulator; Cytoplasm; Disease; Drug Discovery; Dystrophin; Gentamicins; Hearing Loss; Humans; Oligoribonucleotides; Paromomycin; Protein Biosynthesis; RNA Stability; RNA, Ribosomal; Temperature

2009

[Hearing loss associated with paromomycin treatment in a patient with visceral leishmaniasis].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2017, May-01, Volume: 41, Issue:3

Topics: Adult; Antiparasitic Agents; Hearing Loss; Humans; Leishmaniasis, Visceral; Male; Paromomycin

2017